Safety of oral vancomycin in functionally anephric patients.
Administration of a vancomycin oral solution, 2 g daily for 16 days, to functionally anephric patients without inflammatory bowel disease resulted in assayable but low (</=0.66 mug/ml) serum levels in two of the five volunteers.
D000284:Administration, Oral; D000328:Adult; D000368:Aged; D000535:Aluminum / Q000494:pharmacology; D000863:Antacids / Q000494:pharmacology; D002254:Carbonates / Q000494:pharmacology; D004347:Drug Interactions; D006801:Humans; D007676:Kidney Failure, Chronic / Q000378:metabolism*; D008297:Male; D008875:Middle Aged; D014640:Vancomycin / Q000008:administration & dosage / Q000378:metabolism*
D000863:Antacids; D002254:Carbonates; D014640:Vancomycin; D000535:Aluminum